Target Binding Site Detail
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T20401 | Target Info | |||
Target Name | Carbonic anhydrase II (CA-II) | ||||
Synonyms | Carbonic anhydrase C; Carbonic anhydrase 2; Carbonate dehydratase II; CAC | ||||
Target Type | Successful Target | ||||
Gene Name | CA2 | ||||
Biochemical Class | Alpha-carbonic anhydrase | ||||
UniProt ID |
Ligand General Information | Top | ||||
---|---|---|---|---|---|
Ligand Name | 4-{(2S)-2-hydroxy-3-[(propan-2-yl)amino]propoxy}benzene-1-sulfonamide | Ligand Info | |||
Canonical SMILES | CC(C)NCC(COC1=CC=C(C=C1)S(=O)(=O)N)O | ||||
InChI | 1S/C12H20N2O4S/c1-9(2)14-7-10(15)8-18-11-3-5-12(6-4-11)19(13,16)17/h3-6,9-10,14-15H,7-8H2,1-2H3,(H2,13,16,17)/t10-/m0/s1 | ||||
InChIKey | AWVJYQXSBBLZMK-JTQLQIEISA-N | ||||
PubChem Compound ID | 134693730 |
Drug Binding Sites of Target | Top | |||||
---|---|---|---|---|---|---|
PDB ID: 5WLR Carbonic Anhydrase IX-mimic in complex with aryloxy-2-hydroxypropylammine sulfonamide | ||||||
Method | X-ray diffraction | Resolution | 1.49 Å | Mutation | No | [1] |
PDB Sequence |
HWGYGKHNGP
13 EHWHKDFPIA23 KGERQSPVDI33 DTHTAKYDPS43 LKPLSVSYDQ53 ATSLRILNNG 63 HSFQVTFDDS73 QDKAVLKGGP83 LDGTYRLLQF93 HFHWGSLDGQ103 GSEHTVDKKK 113 YAAELHLVHW123 NTKYGDVGKA134 VQQPDGLAVL144 GIFLKVGSAK154 PGLQKVVDVL 164 DSIKTEGKSA174 DFTNFDPRGL184 LPESLDYWTY194 PGSLTTPPLA204 ECVTWIVLKE 214 PISVSSEQVL224 KFRKLNFNGE234 GEPEELMVDN244 WRPAQPLKNR254 QIKASFK |
|||||
|
HIS4
3.967
TRP5
3.456
HIS10
3.502
ASN11
3.649
GLY12
4.605
HIS15
2.875
TRP16
3.314
LYS18
4.010
ASP19
2.709
PHE20
3.865
GLN92
3.889
HIS94
3.254
HIS96
3.324
GLU106
4.103
|
|||||
PDB ID: 5WLT Carbonic Anhydrase IX-mimic in complex with aryloxy-2-hydroxypropylammine sulfonamide | ||||||
Method | X-ray diffraction | Resolution | 1.57 Å | Mutation | No | [2] |
PDB Sequence |
HWGYGKHNGP
13 EHWHKDFPIA23 KGERQSPVDI33 DTHTAKYDPS43 LKPLSVSYDQ53 ATSLRILNNG 63 HAFNVEFDDS73 QDKAVLKGGP83 LDGTYRLIQF93 HFHWGSLDGQ103 GSEHTVDKKK 113 YAAELHLVHW123 NTKYGDFGKA134 VQQPDGLAVL144 GIFLKVGSAK154 PGLQKVVDVL 164 DSIKTKGKSA174 DFTNFDPRGL184 LPESLDYWTY194 PGSLTTPPLL204 ECVTWIVLKE 214 PISVSSEQVL224 KFRKLNFNGE234 GEPEELMVDN244 WRPAQPLKNR254 QIKASFK |
|||||
|
HIS4
3.696
TRP5
3.379
GLY6
4.981
HIS10
3.556
ASN11
3.589
GLY12
4.616
HIS15
2.830
TRP16
3.338
HIS17
4.953
LYS18
3.987
ASP19
2.792
PHE20
3.894
LEU57
4.187
ARG58
4.916
LEU60
3.934
ASN67
3.226
GLU69
2.717
PHE70
4.015
ASP71
2.979
ASP72
2.617
SER73
3.246
ILE91
3.058
GLN92
3.246
HIS94
3.375
HIS96
3.387
GLU106
4.120
HIS119
3.503
VAL121
3.884
TRP123
3.391
GLY129
2.814
ASP130
3.158
PHE131
3.242
GLY132
3.291
VAL135
4.104
LEU141
4.932
VAL143
3.911
SER197
4.143
LEU198
3.460
THR199
2.734
THR200
3.386
PRO201
4.676
PRO202
4.061
LEU204
4.449
TRP209
3.555
|
References | Top | ||||
---|---|---|---|---|---|
REF 1 | Hybrids for multitargeted therapy Beta Adrenergic Receptor modulators CAIs | ||||
REF 2 | Discovery of -Adrenergic Receptors Blocker-Carbonic Anhydrase Inhibitor Hybrids for Multitargeted Antiglaucoma Therapy. J Med Chem. 2018 Jun 28;61(12):5380-5394. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.